Editas Medicine (EDIT) Depreciation & Amortization (CF) (2015 - 2025)
Editas Medicine (EDIT) reported Depreciation & Amortization (CF) of $721000.0 for Q3 2025, down 54.91% year-over-year from $1.6 million in Q3 2024, and down 60.69% on a QoQ basis from $1.8 million in Q2 2025.
Editas Medicine (EDIT) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $721000.0 in Q3 2025.
- Quarterly Depreciation & Amortization (CF) fell 54.91% year-over-year to $721000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (down 23.02% YoY) and the FY2024 annual result came in at $5.8 million, down 4.77% from the prior year.
- Depreciation & Amortization (CF) slipped to $721000.0 in Q3 2025 per EDIT's latest filing, from $1.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.9 million in Q1 2025 and bottomed at $721000.0 in Q3 2025.
- The 5-year median for Depreciation & Amortization (CF) is $1.5 million (2023), against an average of $1.5 million.
- The widest annual swing landed in 2021, when Depreciation & Amortization (CF) surged 45.74%; it then slumped 54.91% in 2025.
- Tracing EDIT's Depreciation & Amortization (CF) over 5 years: stood at $1.6 million in 2021, then climbed by 1.22% to $1.6 million in 2022, then dropped by 4.76% to $1.5 million in 2023, then slipped by 8.06% to $1.4 million in 2024, then slumped by 47.79% to $721000.0 in 2025.
- Per Business Quant, the three latest EDIT Depreciation & Amortization (CF) figures stand at $721000.0 (Q3 2025), $1.8 million (Q2 2025), and $1.9 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 721,000.00 |
| Sep 30, 2025 | 721,000.00 |
| Jun 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 1.19 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 871,000.00 |
| Jun 30, 2020 | 871,000.00 |
| Mar 31, 2020 | 798,000.00 |
| Mar 31, 2020 | 798,000.00 |
| Dec 31, 2019 | 782,000.00 |
| Dec 31, 2019 | 782,000.00 |
| Sep 30, 2019 | 727,000.00 |
| Sep 30, 2019 | 727,000.00 |
| Jun 30, 2019 | 693,000.00 |
| Jun 30, 2019 | 693,000.00 |
| Mar 31, 2019 | 628,000.00 |
| Mar 31, 2019 | 628,000.00 |
| Dec 31, 2018 | 880,000.00 |
| Dec 31, 2018 | 880,000.00 |
| Sep 30, 2018 | 839,000.00 |
| Sep 30, 2018 | 839,000.00 |
| Jun 30, 2018 | 784,000.00 |
| Jun 30, 2018 | 784,000.00 |
| Mar 31, 2018 | 751,000.00 |
| Mar 31, 2018 | 751,000.00 |
| Sep 30, 2017 | 1.97 Mn |
| Sep 30, 2017 | 1.97 Mn |
| Jun 30, 2017 | 1.28 Mn |
| Jun 30, 2017 | 1.28 Mn |
| Mar 31, 2017 | 631,000.00 |
| Mar 31, 2017 | 631,000.00 |
| Dec 31, 2016 | 488,000.00 |
| Dec 31, 2016 | 488,000.00 |
| Sep 30, 2016 | 281,000.00 |
| Sep 30, 2016 | 281,000.00 |
| Jun 30, 2016 | 246,000.00 |
| Jun 30, 2016 | 246,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Mar 31, 2016 | 187,000.00 |
| Dec 31, 2015 | 148,000.00 |
| Dec 31, 2015 | 148,000.00 |
| Sep 30, 2015 | 132,000.00 |
| Sep 30, 2015 | 132,000.00 |
| Jun 30, 2015 | 108,000.00 |
| Jun 30, 2015 | 108,000.00 |
| Mar 31, 2015 | 83,000.00 |
| Mar 31, 2015 | 83,000.00 |